Effects of green tea intake on the development of coronary artery disease

Circulation Journal

Volumn 68, Issue 7, 2004, Pages 665-670

  Sano, Junko ^a   Inami, Shigenobu ^a   Seimiya, Koji ^a   Ohba, Takayoshi ^a   Sakai, Shunta ^a   Takano, Teruo ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Antioxidant; Coronary artery disease; Green tea

Indexed keywords

ANTIOXIDANT; POLYPHENOL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BEVERAGE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TEA;

BEVERAGES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEART CATHETERIZATION; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; PLANT EXTRACTS; PROGNOSIS; RISK FACTORS; TEA;

EID: 3142630111     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.665     Document Type: Article

References (38)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztem JL. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
2. Kita T, Nagano Y, Yokode M, Yokode M, Ishii K, Kume N, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987; 84: 5928-5931.
3. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson M, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786.
4. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet 2000; 356: 1213-1218.
5. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial. Lancet 2002; 359: 1108-1113.
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360: 23-33.
7. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zetphen Elderly Study. Lancet 1993; 342: 1007-1011.
8. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Tea consumption and mortality after acute myocardial infarction. Circulation 2002; 105: 2476-2481.
9. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
10. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457.
11. Kondo K, Matsumoto A, Kurata H, Tanahashi H, Koda H, Amachi T, et al. Inhibition of oxidation of low-density lipoprotein with red wine. Lancet 1994; 344: 1152.
12. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989; 79: 245-252.
13. Tanabe N, Saito R, Sato T, Hayashi S, Toyoshima H, Seki N, et al. Event rates of acute myocardial infarction and coronary deaths in Niigata and Nagaoka cities in Japan. Circ J 2003; 67: 40-45.
14. Hirano R, Momiyama Y, Takahashi R, Taniguchi H, Kondo K, Nakamura H, et al. Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol 2002; 90: 1150-1153.
15. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LSC, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1995; 51: 5-40.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
17. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995; 310: 693-696.
20. Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, et al. Possible contribution of green tea drinking habits to the prevenfion of stroke. Tohoku J Exp Med 1989; 157: 337-343.
21. Sakazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 2000; 10: 401-408.
22. Research committee on serum lipid level survey 1990 in Japan. Current state of and recent trends in serum lipid levels in the general Japanese population. J Atheroscler Thromb 1996; 2: 122-132.
23. Verschuren WMM, Jacobs DR, Bloemberg BPM, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty-five-year follow-up of the Seven Countries Study. JAMA 1995; 274: 131-136.
24. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995; 155: 381-386.
25. Tijburg LBM, Wiseman SA, Meijer GW, Weststrate JA. Effects of green tea, black tea and dietary lipophlic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 1997; 135: 37-47.
26. Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JCM. Tea flavonoids may protect against atherosclerosis: The Rotterdam Study. Arch Intern Med 1999; 159: 2170-2174.
27. Okuda T, Kimura Y, Yoshida T, Hatano T, Okuda H, Arichi S. Studies on the activities of tannins and related compounds from medicinal plants and drugs. I: Inhibitory effects of lipid peroxidation in mitochondria and microsomes of liver. Chem Pharm Bull 1983; 31: 1625-1631.
28. Yoshino K, Tomita I, Sano M, Oguni I, Hara Y, Nakano M. Effects of long-term dietary supplement of tea polyphenols on lipid peroxide levels in rats. Age 1994; 17: 79-85.
29. Sano M, Takahashi Y, Yoshino K, Shimoi K, Nakamura Y, Tomita I, et al. Effects of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: A comparison of green and black tea feeding. Biol Pharm Bull 1995; 18: 1006-1008.
30. Serafini M, Ghiselli A, Ferro-Luzzi A. Red wine, tea, and antioxidants. Lancet 1994; 344: 626.
31. Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, et al. Effects of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997; 66: 261-266.
32. Duffy SJ, Keaney JF, Holbrook M, Gokce N, Swerdloff PL, Frei B, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001; 104: 151-156.
33. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 1986; 32: 613-622.
34. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, et al. Cholesterol-lowering effect of theaflavin-enriched green tea extract: A randomized controlled trial. Arch Intern Med 2003; 163: 1448-1453.
35. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y. Reduction of blood glucose levels by tea catechin. Biosci Biotechnol Biochem 1993; 57: 525-527.
36. Sagesaka-Mitane Y, Miwa M, Okada S. Platelet aggregation inhibitors in hot water extract of green tea. Chem Pharm Bull (Tokyo) 1990; 38: 790-793.
37. Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 1999; 96: 229-237.
38. Ministry of Health and Welfare. The third national survey of circulatory disorders 1980. Tokyo: Japan Heart Foundation, 1983 (in Japanese).